Publications by authors named "Vitor Teixeira Liutti"

Breast cancer metastatic to parotid gland is a very rare condition which tend to confer poor prognosis and challenging approaches. Oligometastatic breast cancer is usually defined as advanced breast cancer with less or equal than 5 metastatic lesions. We report a case of oligometastatic HER-2 breast cancer to parotid gland and lymph nodes which presented with left hemifacial swelling with erythema and enlargement of cervical and axillary lymph nodes.

View Article and Find Full Text PDF
Article Synopsis
  • Abnormalities in the intrinsic apoptosis pathway, specifically linked to single nucleotide variants (SNVs) in caspase genes, were found to affect the progression and proliferation of head and neck squamous cell carcinoma (HNSCC).
  • This study evaluated the impact of CASP9 c.-1339A>G and CASP3 c.-1191A>G SNVs on patient outcomes by analyzing DNA and RNA from 262 HNSCC patients using real-time PCR methods.
  • Results indicated that specific genotypes (CASP3 c.-1191AG/GG and CASP9 c.-1339GG) correlated with increased risk of disease progression and death, suggesting these genetic variants could serve as predictors for survival in
View Article and Find Full Text PDF

Objective: This report is aimed at describing a rare clinical condition of advanced esophageal cancer with subcutaneous metastasis.

Case Report: The present case refers to a patient diagnosed with stage IV esophageal squamous cell carcinoma which started with dysphonia and cervical nodules. Soon after that, the patient developed dysphagia and subcutaneous lesions on the right flank.

View Article and Find Full Text PDF

Introduction: The role of neoadjuvant endocrine therapy for resectable breast cancer is not well established, despite encouraging results obtained in the metastatic and adjuvant settings. This systematic review aims to examine existing medical literature on neoadjuvant hormone therapy (HT).

Methods: Data from prospective, randomized trials was included if comparing neoadjuvant HT versus surgery alone without adjuvant treatment, or neoadjuvant HT versus chemotherapy (CT), or HT plus CT versus CT alone, or HT plus CT versus HT alone, or two distinct HT.

View Article and Find Full Text PDF